Accelerating R&D Decisions by 50% and Cutting Evidence Search by 60%: A Secure AI Intelligence Platform for Global Pharma

Overview

The ClientThe client is a global pharmaceutical company headquartered in Europe, with around 4,000 employees across its research and development organization.

To unlock the hidden potential of historical R&D data and accelerate research discovery, ROI & Shine architected a secure, decision-support AI platform for a European pharmaceutical leader. By transforming siloed clinical data into a unified, graph-based intelligence ecosystem, this enterprise solution empowers scientists with an intelligent research copilot. We engineered a system that drastically reduces evidence-search and analysis time while guaranteeing strict data provenance, keeping medical experts and authorized decision-makers firmly in control of a continuously growing institutional knowledge base.

The Challenge

In pharmaceutical R&D, rapid innovation requires flawless data analysis. However, the client's highly qualified scientists were severely bottlenecked by legacy infrastructure and process friction:

• Severe Data FragmentationDecades of intellectual capital were scattered across laboratory systems, clinical platforms, spreadsheets, statistical tools, and archived project folders.
• Trapped Unstructured KnowledgeCritical clinical insights were locked within PDFs, laboratory notes, and scientific narratives, making scalable extraction impossible.
• Complex ComparabilityManually comparing studies was highly error-prone due to material differences in populations, dosages, protocols, endpoints, and laboratory conditions.
• The Hallucination RiskGeneric Large Language Models pose unacceptable scientific, operational, and reputational risks. In pharma, AI cannot simply generate plausible text; it must strictly distinguish association from scientific causation and adhere to rigid regulatory profiles.

The Strategy

We approached this not as a simple search implementation, but as the design of a mission-critical scientific decision-support system.

Our strategy prioritized governance, accuracy, and rigorous methodology before a single model was deployed:

• Unified Pharmaceutical Data ModelWe conducted a strict inventory of 8-12 priority repositories, standardizing critical scientific terminology, units, and metadata to establish a governed intelligence layer.
• Zero-Hallucination ArchitectureWe engineered the platform to require citations at the specific claim level. If evidence is insufficient, the system is actively prevented from answering. The original document is always retained as the authoritative reference.
• Phase-Gate Delivery GovernanceTo manage enterprise risk, we deployed the solution through five rigorous validation milestones: Business Value, Data Readiness, Scientific Quality, Operational Readiness, and a final Scale Decision.

The Solution

ROI & Shine deployed a secure enterprise platform featuring an Intelligent Research Copilot that seamlessly automates complex data orchestration native to the client's secure environment:

1. 1

   Integrates & Searches

   The copilot connects disparate repositories, interpreting complex R&D questions expressed in natural language to locate historical studies, experiments, and scientific documentation.

2. 2

   Extracts & Compares

   Utilizing controlled document classification pipelines, the AI identifies relationships between experimental conditions and observed outcomes, seamlessly comparing results across research phases, compounds, and protocols.

3. 3

   Verify - Source Traceability

   Every single answer, claim, and data point generated by the platform is instantly traceable back to its exact source document, entirely mitigating hallucination risk.

4. 4

   Preserves Knowledge

   Beyond capturing study results, the platform documents the interpretation and reasoning behind human research decisions, converting them into a structured, reusable knowledge base for future teams.

The Impact

By aligning robust data engineering with deep pharmaceutical compliance, ROI & Shine transformed historical research data into an active operational advantage, drastically shrinking the time required to execute complex R&D decisions.